Investing.com - Financial Markets Worldwide

Qingdao Baheal Medical Inc (301015)

Shenzhen
Currency in CNY
24.99
+0.98(+4.08%)
Closed·
301015 Scorecard
Full Analysis
RSI suggests the stock is in overbought territory
301015 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
23.9325.14
52 wk Range
17.3735.90
Key Statistics
Edit
Bid/Ask
24.99 / 24.99
Prev. Close
24.01
Open
24.02
Day's Range
23.93-25.14
52 wk Range
17.37-35.9
Volume
15.92M
Average Volume (3m)
12.2M
1-Year Change
4.79%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
301015 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
24.33
Downside
-2.64%
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 8
Significant return over the last week
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Qingdao Baheal Medical Inc Company Profile

Qingdao Baheal Medical INC. engages in the research and development, production, wholesale, and retail of pharmaceutical products in China, the United States, Hong Kong, and the United Kingdom. The company offers bone health drugs under the D-Cal brand name; digestive drugs under the Mite brand name; liver disease drugs under the Fuzhenghuayu brand name; and urological drugs under the Betanli, Harle, and Wei Xi Kang brand names. It also provides ophthalmic drugs under the HYCOSAN brand name; tumor and other severe drugs under the Human Albumin and Xospata brand names; anti-aging and cosmeceuticals under the Quanis, Excellula, TRANSINO, and Qingchunbao brand names; diabetes drugs under the Naida, Feburic, and Naite brand names; respiratory and anti-infective products under the Klacid brand name; and medical nutrition under the Nutrasumma brand name. The company was incorporated in 2005 and is based in Qingdao, China. Qingdao Baheal Medical INC. is a subsidiary of BAHEAL Pharmaceutical Holdings Limited.

Industry
Pharmaceuticals
Sector
Healthcare
Employees
3064
Market
China

Compare 301015 to Peers and Sector

Metrics to compare
301015
Peers
Sector
Relationship
P/E Ratio
22.3x21.1x−0.5x
PEG Ratio
−0.96−0.370.00
Price/Book
5.3x1.0x2.6x
Price / LTM Sales
1.6x0.6x3.3x
Upside (Analyst Target)
−2.6%19.1%43.4%
Fair Value Upside
Unlock23.9%7.1%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 24.33
(-2.64% Downside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.13%
Dividend Yield
3.05%
Industry Median 1.51%
Annualised payout
0.76
Paid annually
5-Years Growth
-
Growth Streak
Unlock

Earnings

Latest Release
Apr 23, 2025
EPS / Forecast
0.16 / --
Revenue / Forecast
1.84B / --
EPS Revisions
a
a
Unlock
Last 90 days

301015 Income Statement

FAQ

What Stock Exchange Does Qingdao Baheal Medical Trade On?

Qingdao Baheal Medical is listed and trades on the Shenzhen Stock Exchange stock exchange.

What Is the Stock Symbol for Qingdao Baheal Medical?

The stock symbol for Qingdao Baheal Medical is "301015."

What Is the Qingdao Baheal Medical Market Cap?

As of today, Qingdao Baheal Medical market cap is 13.14B.

What Is Qingdao Baheal Medical's Earnings Per Share (TTM)?

The Qingdao Baheal Medical EPS (TTM) is 1.13.

When Is the Next Qingdao Baheal Medical Earnings Date?

Qingdao Baheal Medical will release its next earnings report on 23 Oct 2025.

From a Technical Analysis Perspective, Is 301015 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Qingdao Baheal Medical Stock Split?

Qingdao Baheal Medical has split 0 times.

How Many Employees Does Qingdao Baheal Medical Have?

Qingdao Baheal Medical has 3064 employees.

What is the current trading status of Qingdao Baheal Medical (301015)?

As of 08 Aug 2025, Qingdao Baheal Medical (301015) is trading at a price of 24.99, with a previous close of 24.01. The stock has fluctuated within a day range of 23.93 to 25.14, while its 52-week range spans from 17.37 to 35.90.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.